Antiphospholipid antibodies and platelets (Q34108963)

31 July 2017

1 reference

title

Antiphospholipid antibodies and platelets. (English)

1 reference

31 July 2017

De Jong A

1

1 reference

31 July 2017

Ziboh V

series ordinal

2

1 reference

31 July 2017

Robbins D

series ordinal

3

1 reference

31 July 2017

publication date

1 June 2000

1 reference

Current Rheumatology Reports

31 July 2017

published in

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

238-245

1 reference

Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I

31 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-000-0085-8

Molecular studies on phospholipid-binding sites and cryptic epitopes appearing on beta 2-glycoprotein I structure recognized by anticardiolipin antibodies

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-000-0085-8

Transbilayer movement of phospholipids in red cell and platelet membranes

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-000-0085-8

Molecular basis of the apolipoprotein H (beta 2-glycoprotein I) protein polymorphism

21 January 2018

1 reference

12 December 2020

Demonstration of antiphospholipid antibody heterogeneity by phospholipid column chromatography and salt gradient elution techniques

1 reference

12 December 2020

Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody

1 reference

12 December 2020

Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor

1 reference

12 December 2020

Pathogenic role of antiprotein-phospholipid antibodies

1 reference

12 December 2020

Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986

1 reference

12 December 2020

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

1 reference

12 December 2020

Platelet activation in patients with antiphospholipid syndrome.

1 reference

12 December 2020

Isolation and purification of anticardiolipin antibody from plasma of a patient with antiphospholipid syndrome: induced generation of platelet thromboxane A2 synthesis

1 reference

12 December 2020

Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics.

1 reference

12 December 2020

Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I

1 reference

12 December 2020

Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen

1 reference

12 December 2020

Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?

1 reference

12 December 2020

Immunoelectrophoresis and ELISA techniques for assay of plasma beta 2 glycoprotein-1 and the influence of plasma lipids.

1 reference

12 December 2020

Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.

1 reference

12 December 2020

Role of the N- and C-terminal domains of bovine beta 2-glycoprotein I in its interaction with cardiolipin

1 reference

12 December 2020

Tyrosine phosphorylation and activation of mitogen-activated protein kinases by thrombin in human platelets: possible involvement in late arachidonic acid release

1 reference

12 December 2020

Cytosolic phospholipase A2

1 reference

12 December 2020

Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion

1 reference

12 December 2020

Beta 2-glycoprotein 1 (beta 2GP1) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodies

1 reference

12 December 2020

Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets

1 reference

12 December 2020

The fifth domain of beta 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies.

1 reference

12 December 2020

Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipid

1 reference

12 December 2020

Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies

1 reference

12 December 2020

Phosphatidylinositol-derived precursors and signals

1 reference

12 December 2020

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

1 reference

12 December 2020

Thrombin induces activation of p38 MAP kinase in human platelets

1 reference

12 December 2020

IgA anticardiolipin antibodies--relation with other antiphospholipid antibodies and clinical significance.

1 reference

12 December 2020

Mechanism and effects of the binding of lupus anticoagulant IgG and prothrombin to surface phospholipid

1 reference

12 December 2020

Immunology and Clinical Importance of Antiphospholipid Antibodies

1 reference

12 December 2020

Crossreactivity of antiphospholipid antibodies

1 reference

12 December 2020

Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects

1 reference

12 December 2020

Lupus anticoagulants form immune complexes with prothrombin and phospholipid that can augment thrombin production in flow

1 reference

12 December 2020

The clinical significance of platelet membrane glycoproteins

1 reference

12 December 2020

T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals

1 reference

12 December 2020

10.1007/S11926-000-0085-8

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1007519003

0 references

1 reference